Regen BioPharma, Inc.

Regen BioPharma, Inc.

RGBP - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$61.56K
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Regen BioPharma, Inc.Regen BioPharma, Inc.0-20%--0.2

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$61,556.00
Enterprise Value$986,037.00
Earnings per Share$-0.05
Beta0.23
Outstanding Shares615,555,666

Return

Return on Equity20.18%ROE
Return on Assets-412.46%
Return on Invested Capital19.62%

Valuation & Multiples

P/E Ratio-0.01P/E Ratio
PEG0PEG
Price to Sales-Price to Sales
Price to Book Ratio-0.0Price to Book Ratio
Enterprise Value to Revenue4.17
Enterprise Value to EBIT-0.86
Enterprise Value to Net Income-1
Total Debt to Enterprise0.94
Debt to Equity-0.16Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
August 17, 2026
EPS
-$0.00
Reported
Revenue
$59,065
Reported

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Regen BioPharma, Inc.

1 employees
CEO: David Raymond Koos

Regen BioPharma, Inc. is a company dedicated to advancing regenerative medicine within the United States. It actively researches and identifies small molecule compounds designed to modulate the NR2F6 gene. This modulation is strategicall...